Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Lambert

Showing results (111-120 of 167) with videos related to

Pageof 17
Sort By:
Schizophrenia Research|October 10, 2008
Long-term patterns of subjective wellbeing in schizophrenia: cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 yearsMartin Lambert, Benno G Schimmelmann, Alexander Schacht, et al.
Psychiatrische Praxis|May 3, 2023
[Assessment of Direct (COVID-19-Related) and Collateral, Psychosocial Pandemic Consequences for Vulnerable Groups by the Example of Serious Mental Illness]Leonie Ascone, Anja Christine Rohenkohl, René Hurlemann, et al.
The International Journal of Neuropsychopharmacology|September 22, 2005
Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapineStefan Bender, Alexandra Dittmann-Balcar, Ulrich Schall, et al.
Journal of Child and Adolescent Psychopharmacology|March 5, 2008
A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disordersBenno Graf Schimmelmann, Claudia Mehler-Wex, Martin Lambert, et al.
International Journal of Environmental Research and Public Health|April 26, 2025
Mental Health in the Time of the COVID-19 Pandemic: A Scoping Review of Collateral Effects on Common Mental Disorders (CMDs)Anna Maria Höhn, Leonie Ascone, Luzie Lohse, et al.
Psychiatry Research|January 26, 2016
Changes in beliefs and attitudes toward people with depression and schizophrenia - results of a public campaign in GermanyAnna C Makowski, Eva E Mnich, Julia Ludwig, et al.
Frontiers in Psychiatry|November 4, 2021
Parents With Mental Illness: Parental Coping Behavior and Its Association With Children's Mental HealthMarlit Sell, Alina Radicke, Bonnie Adema, et al.
Frontiers in Psychiatry|November 12, 2019
Reduction of Involuntary Admissions in Patients With Severe Psychotic Disorders Treated in the ACCESS Integrated Care Model Including Therapeutic Assertive Community TreatmentDaniel Schöttle, Friederike Ruppelt, Benno G Schimmelmann, et al.
Psychiatrische Praxis|January 9, 2025
[Rapid Assessment of Future Pandemic Effects in Individuals with Severe Mental Illness: Can Ongoing Population-Representative Cohorts Contribute?]Felix G Wittmann, Melanie Luppa, Anna Höhn, et al.
The Journal of Clinical Psychiatry|April 12, 2012
Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial)Anne Karow, Jens Reimer, Hans Helmut König, et al.
Pageof 17

Showing results (111-120 of 167) with videos related to

Sort By:
Pageof 17
Schizophrenia Research|October 10, 2008
Long-term patterns of subjective wellbeing in schizophrenia: cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 yearsMartin Lambert, Benno G Schimmelmann, Alexander Schacht, et al.
Psychiatrische Praxis|May 3, 2023
[Assessment of Direct (COVID-19-Related) and Collateral, Psychosocial Pandemic Consequences for Vulnerable Groups by the Example of Serious Mental Illness]Leonie Ascone, Anja Christine Rohenkohl, René Hurlemann, et al.
The International Journal of Neuropsychopharmacology|September 22, 2005
Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapineStefan Bender, Alexandra Dittmann-Balcar, Ulrich Schall, et al.
Journal of Child and Adolescent Psychopharmacology|March 5, 2008
A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disordersBenno Graf Schimmelmann, Claudia Mehler-Wex, Martin Lambert, et al.
International Journal of Environmental Research and Public Health|April 26, 2025
Mental Health in the Time of the COVID-19 Pandemic: A Scoping Review of Collateral Effects on Common Mental Disorders (CMDs)Anna Maria Höhn, Leonie Ascone, Luzie Lohse, et al.
Psychiatry Research|January 26, 2016
Changes in beliefs and attitudes toward people with depression and schizophrenia - results of a public campaign in GermanyAnna C Makowski, Eva E Mnich, Julia Ludwig, et al.
Frontiers in Psychiatry|November 4, 2021
Parents With Mental Illness: Parental Coping Behavior and Its Association With Children's Mental HealthMarlit Sell, Alina Radicke, Bonnie Adema, et al.
Frontiers in Psychiatry|November 12, 2019
Reduction of Involuntary Admissions in Patients With Severe Psychotic Disorders Treated in the ACCESS Integrated Care Model Including Therapeutic Assertive Community TreatmentDaniel Schöttle, Friederike Ruppelt, Benno G Schimmelmann, et al.
Psychiatrische Praxis|January 9, 2025
[Rapid Assessment of Future Pandemic Effects in Individuals with Severe Mental Illness: Can Ongoing Population-Representative Cohorts Contribute?]Felix G Wittmann, Melanie Luppa, Anna Höhn, et al.
The Journal of Clinical Psychiatry|April 12, 2012
Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial)Anne Karow, Jens Reimer, Hans Helmut König, et al.
Pageof 17